The Microarray Innovations in Leukemia study assessed the clinical utility of gene expression profiling as a single test to subtype leukemias into conventional categories of myeloid and lymphoid ...

Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group. If you ...

We analyzed expression of 7,075 genes in four conventional renal cell carcinomas (RCCs), one chromophobe RCC, and two oncocytomas using complementary DNA microarrays. Expression profiles were compared ...

BUFFALO, N.Y. -- A multidisciplinary team of pharmaceutics and computer-science researchers at the University at Buffalo, one of very few teams in the nation applying DNA microarray technology in ...

TATAA Biocenter is expanding its offerings to high-throughput microRNA and mRNA profiling using Toray´s technology of 3D-Gene™ microarray. “The number of microRNAs discovered is steadily increasing.

Though DNA microarrays let researchers rapidly identify the expression levels of genes associated with diseases and pathways, they say little about how much protein these transcripts produce. A new ...

The biggest news these days in tissue microarrays (TMAs) may be that this former "next big thing" has become a standard tool for molecular profiling of disease. Some 682 papers have been published on ...

A study published in the May issue of Developmental Cell identifies specific genes that appear to be key players in the regulation of human-blood stem cells. This work is the first to validate gene ...

U.S. Gene Expression Analysis Market size is USD 1.28 Billion in 2025 and is expected to reach USD 2.45 Billion by 2035 owing to high penetration of advanced molecular analysis technologies.Austin, ...

Agencourt Bioscience, a wholly-owned subsidiary of Beckman Coulter (BEC), NuGEN Technologies, and Affymetrix Clinical Services Laboratory announce a collaboration that has yielded a service offering ...